Nitric oxide and cardiobiology-methods for intact hearts and isolated myocytes

被引:11
作者
Hare, Joshua M.
Beigi, Farideh
Tziomalos, Konstantinos
机构
来源
NITRIC OXIDE, PT G: OXIDATIVE AND NITROSATIVE STRESS IN REDOX REGULATION OF CELL SIGNALING | 2008年 / 441卷
关键词
D O I
10.1016/S0076-6879(08)01221-4
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The cross talk between reactive oxygen species (ROS) and reactive nitrogen species (RNS) plays a pivotal role in the regulation of myocardial and vascular function. Both nitric oxide and redox-based signaling involve the posttranstational modification of proteins through S-nitrosylation and oxidation of specific cysteine residues. Disruption of this cross talk between ROS and RNS contributes to the pathogenesis of heart failure. Therefore, the elucidation of these complex chemical interactions may improve our understanding of cardiovascular patho physiology. This chapter discusses the significant role of spatial confinement of nitric oxide synthases, NADPH oxidase, and xanthine oxidoreductase in the regulation of myocardial excitation-contraction coupling. This chapter describes techniques for assessing oxidative and nitrosative stress. A variety of assays have been developed that quantify S-nitrosylated proteins. Among them, the biotin-switch method directly evaluates endogenously nitrosylated proteins in a reproducible way. Identification of the biotinylated or S-nitrosylated proteins subjected to the biotin-switch assay are described and evaluated with a one-dimensional gel (Western blot) or with the newly developed two-dimensional fluorescence difference get electrophoresis proteomic analysis. Quantifying the number of free thiols with the monobromobimane assay in a protein of interest allows estimation of cysteine oxidation and, in turn, the state of nitroso-redox balance of effector molecules. In summary, this chapter reviews the biochemical methods that assess the impact of nitroso/redox signaling in the cardiovascular system.
引用
收藏
页码:369 / 392
页数:24
相关论文
共 86 条
[1]   Inflammatory biomarkers in acute coronary syndromes - Part III: Biomarkers of oxidative stress and angiogenic growth factors [J].
Armstrong, EJ ;
Morrow, DA ;
Sabatine, MS .
CIRCULATION, 2006, 113 (08) :E289-E292
[2]   SUPEROXIDE ANION INVOLVEMENT IN NBT REDUCTION CATALYZED BY NADPH-CYTOCHROME RHO-450 REDUCTASE - PITFALL [J].
AUCLAIR, C ;
TORRES, M ;
HAKIM, J .
FEBS LETTERS, 1978, 89 (01) :26-28
[3]   Nitric oxide regulates the heart by spatial confinement of nitric oxide synthase isoforms [J].
Barouch, LA ;
Harrison, RW ;
Skaf, MW ;
Rosas, GO ;
Cappola, TP ;
Kobeissi, ZA ;
Hobai, IA ;
Lemmon, CA ;
Burnett, AL ;
O'Rourke, B ;
Rodriguez, ER ;
Huang, PL ;
Lima, JAC ;
Berkowitz, DE ;
Hare, JM .
NATURE, 2002, 416 (6878) :337-340
[4]   A simpler, more robust method for the analysis of 8-oxoguanine in DNA [J].
Beckman, KB ;
Saljoughi, S ;
Mashiyama, ST ;
Ames, BN .
FREE RADICAL BIOLOGY AND MEDICINE, 2000, 29 (3-4) :357-367
[5]   Xanthine oxicloreductase and cardiovascular disease: molecular mechanisms and pathophysiological implications [J].
Berry, CE ;
Hare, JM .
JOURNAL OF PHYSIOLOGY-LONDON, 2004, 555 (03) :589-606
[6]   Determination of isoprostaglandin F2α type III in human urine by gas chromatography-electronic impact mass spectrometry.: Comparison with enzyme immunoassay [J].
Bessard, J ;
Cracowski, JL ;
Stanke-Labesque, F ;
Bessard, G .
JOURNAL OF CHROMATOGRAPHY B, 2001, 754 (02) :333-343
[7]   Direct detection of reactive oxygen species ex vivo [J].
Brandes, RP ;
Janiszewski, M .
KIDNEY INTERNATIONAL, 2005, 67 (05) :1662-1664
[8]   8-nitro-2′-deoxyguanosine, a specific marker of oxidation by reactive nitrogen species, is generated by the myeloperoxidase hydrogen peroxide nitrite system of activated human phagocytes [J].
Byun, J ;
Henderson, JP ;
Mueller, DM ;
Heinecke, JW .
BIOCHEMISTRY, 1999, 38 (08) :2590-2600
[9]   Redox modulation of L-type calcium channels in ferret ventricular myocytes - Dual mechanism regulation by nitric oxide and S-nitrosothiols [J].
Campbell, DL ;
Stamler, JS ;
Strauss, HC .
JOURNAL OF GENERAL PHYSIOLOGY, 1996, 108 (04) :277-293
[10]   Allopurinol improves myocardial efficiency in patients with idiopathic dilated cardiomyopathy [J].
Cappola, TP ;
Kass, DA ;
Nelson, GS ;
Berger, RD ;
Rosas, GO ;
Kobeissi, ZA ;
Marbán, E ;
Hare, JM .
CIRCULATION, 2001, 104 (20) :2407-2411